To test this hypothesis we generated and characterized AGXT2 transgenic mice and determined, whether this transgene can protect Ddah1 knockout mice from ADMA elevation, endothelial dysfunction and aortic remodeling. Here, DDAH1 is linked to endothelial dysfunction.